Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn’s Disease

Stefan Schreiber, Scott D Lee, C Janneke van der Woude, Ignacio Marín-Jiménez, Douglas C Wolf, Elisabeth Schnoy, Bruce Salzberg, Christopher Busse, Maciej Nazar, Tony Ma, Stephan Borghorst, Christopher Gasink, Thomas Baker, Bridget Godwin, Omoniyi J Adedokun, Brian G Feagan, Unknown, Scott Lee, Douglas Wolf, Bruce Salzberg, Elisabeth Schnoy, Stefan Schreiber, Jochen Klaus, Herbert Deppe, Anita Afzali, Thomas Krause, Yoram Bouhnik, Torsten Kucharzik, Oksana Shchukina, Renate Schmelz, Milan Lukas, Stephane Nancey, Byong Duk Ye, George DuVall, Stefanie Howaldt, Caprioli Flavio, Hyo-Jong Kim, Kamal Patel, Yoram Bouhnik, Pierre Blanc, Irina Blumenstein, Manreet Kaur, Jimmy Limdi, Annette Krummenerl, Peter Hasselblatt, Pilar Lopez Serrano, Ulf Helwig, Alessandro Armuzzi, Ana Echarri, Udayakumar Navaneethan, Britta Siegmund, Xavier Calvet Calvo, Parambir Dulai, Laurent Peyrin Biroulet, Wolfgang Reindl, Jeroen Jansen, Ignacio Marin Jimenez, Cristina Rodriquez Gutierrez, Raquel Vincente Lidon, Jessica Allegretti, Helga Török, Ji-Hye Park, Desirée Leemreis, Olga Fedorishina, Dawn Beaulieu, Sarah Glover, Charles Randall, Rodolfo Rocca, Mikael Lördal, William Holderman, Heba Iskandar, Laura Loy, Simone Saibeni, Maria Dolores Martin Arranz, Montserrat Rivero Tirado, Bincy Abraham, Robert Hirten, Tomas Vanasek, Guillaume Boughen, Pierre Desreumaux, Wolfgang Mohl, Taeoh Kim, Andrea van der Meulen, Pavel Makarchuk, Francis Farraye, Alexandra Kent

Open source

DOI
10.1093/ibd/izaf163
Published
2025-09-02
Container
Inflammatory Bowel Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ibd/izaf163,
  title = {Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn’s Disease},
  author = {Stefan Schreiber and Scott D Lee and C Janneke van der Woude and Ignacio Marín-Jiménez and Douglas C Wolf and Elisabeth Schnoy and Bruce Salzberg and Christopher Busse and Maciej Nazar and Tony Ma and Stephan Borghorst and Christopher Gasink and Thomas Baker and Bridget Godwin and Omoniyi J Adedokun and Brian G Feagan and Unknown and Scott Lee and Douglas Wolf and Bruce Salzberg and Elisabeth Schnoy and Stefan Schreiber and Jochen Klaus and Herbert Deppe and Anita Afzali and Thomas Krause and Yoram Bouhnik and Torsten Kucharzik and Oksana Shchukina and Renate Schmelz and Milan Lukas and Stephane Nancey and Byong Duk Ye and George DuVall and Stefanie Howaldt and Caprioli Flavio and Hyo-Jong Kim and Kamal Patel and Yoram Bouhnik and Pierre Blanc and Irina Blumenstein and Manreet Kaur and Jimmy Limdi and Annette Krummenerl and Peter Hasselblatt and Pilar Lopez Serrano and Ulf Helwig and Alessandro Armuzzi and Ana Echarri and Udayakumar Navaneethan and Britta Siegmund and Xavier Calvet Calvo and Parambir Dulai and Laurent Peyrin Biroulet and Wolfgang Reindl and Jeroen Jansen and Ignacio Marin Jimenez and Cristina Rodriquez Gutierrez and Raquel Vincente Lidon and Jessica Allegretti and Helga Török and Ji-Hye Park and Desirée Leemreis and Olga Fedorishina and Dawn Beaulieu and Sarah Glover and Charles Randall and Rodolfo Rocca and Mikael Lördal and William Holderman and Heba Iskandar and Laura Loy and Simone Saibeni and Maria Dolores Martin Arranz and Montserrat Rivero Tirado and Bincy Abraham and Robert Hirten and Tomas Vanasek and Guillaume Boughen and Pierre Desreumaux and Wolfgang Mohl and Taeoh Kim and Andrea van der Meulen and Pavel Makarchuk and Francis Farraye and Alexandra Kent},
  year = {2025},
  journal = {Inflammatory Bowel Diseases},
  doi = {10.1093/ibd/izaf163},
  url = {https://doi.org/10.1093/ibd/izaf163}
}

RIS

TY  - JOUR
TI  - Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn’s Disease
AU  - Stefan Schreiber
AU  - Scott D Lee
AU  - C Janneke van der Woude
AU  - Ignacio Marín-Jiménez
AU  - Douglas C Wolf
AU  - Elisabeth Schnoy
AU  - Bruce Salzberg
AU  - Christopher Busse
AU  - Maciej Nazar
AU  - Tony Ma
AU  - Stephan Borghorst
AU  - Christopher Gasink
AU  - Thomas Baker
AU  - Bridget Godwin
AU  - Omoniyi J Adedokun
AU  - Brian G Feagan
AU  - Unknown
AU  - Scott Lee
AU  - Douglas Wolf
AU  - Bruce Salzberg
AU  - Elisabeth Schnoy
AU  - Stefan Schreiber
AU  - Jochen Klaus
AU  - Herbert Deppe
AU  - Anita Afzali
AU  - Thomas Krause
AU  - Yoram Bouhnik
AU  - Torsten Kucharzik
AU  - Oksana Shchukina
AU  - Renate Schmelz
AU  - Milan Lukas
AU  - Stephane Nancey
AU  - Byong Duk Ye
AU  - George DuVall
AU  - Stefanie Howaldt
AU  - Caprioli Flavio
AU  - Hyo-Jong Kim
AU  - Kamal Patel
AU  - Yoram Bouhnik
AU  - Pierre Blanc
AU  - Irina Blumenstein
AU  - Manreet Kaur
AU  - Jimmy Limdi
AU  - Annette Krummenerl
AU  - Peter Hasselblatt
AU  - Pilar Lopez Serrano
AU  - Ulf Helwig
AU  - Alessandro Armuzzi
AU  - Ana Echarri
AU  - Udayakumar Navaneethan
AU  - Britta Siegmund
AU  - Xavier Calvet Calvo
AU  - Parambir Dulai
AU  - Laurent Peyrin Biroulet
AU  - Wolfgang Reindl
AU  - Jeroen Jansen
AU  - Ignacio Marin Jimenez
AU  - Cristina Rodriquez Gutierrez
AU  - Raquel Vincente Lidon
AU  - Jessica Allegretti
AU  - Helga Török
AU  - Ji-Hye Park
AU  - Desirée Leemreis
AU  - Olga Fedorishina
AU  - Dawn Beaulieu
AU  - Sarah Glover
AU  - Charles Randall
AU  - Rodolfo Rocca
AU  - Mikael Lördal
AU  - William Holderman
AU  - Heba Iskandar
AU  - Laura Loy
AU  - Simone Saibeni
AU  - Maria Dolores Martin Arranz
AU  - Montserrat Rivero Tirado
AU  - Bincy Abraham
AU  - Robert Hirten
AU  - Tomas Vanasek
AU  - Guillaume Boughen
AU  - Pierre Desreumaux
AU  - Wolfgang Mohl
AU  - Taeoh Kim
AU  - Andrea van der Meulen
AU  - Pavel Makarchuk
AU  - Francis Farraye
AU  - Alexandra Kent
PY  - 2025
JO  - Inflammatory Bowel Diseases
DO  - 10.1093/ibd/izaf163
UR  - https://doi.org/10.1093/ibd/izaf163
ER  - 

APA

Schreiber, S., Lee, S. D., Woude, C. J. V. D., Marín-Jiménez, I., Wolf, D. C., Schnoy, E., Salzberg, B., Busse, C., Nazar, M., Ma, T., Borghorst, S., Gasink, C., Baker, T., Godwin, B., Adedokun, O. J., Feagan, B. G., Unknown, Lee, S., Wolf, D., Salzberg, B., Schnoy, E., Schreiber, S., Klaus, J., Deppe, H., Afzali, A., Krause, T., Bouhnik, Y., Kucharzik, T., Shchukina, O., Schmelz, R., Lukas, M., Nancey, S., Ye, B. D., DuVall, G., Howaldt, S., Flavio, C., Kim, H., Patel, K., Bouhnik, Y., Blanc, P., Blumenstein, I., Kaur, M., Limdi, J., Krummenerl, A., Hasselblatt, P., Serrano, P. L., Helwig, U., Armuzzi, A., Echarri, A., Navaneethan, U., Siegmund, B., Calvo, X. C., Dulai, P., Biroulet, L. P., Reindl, W., Jansen, J., Jimenez, I. M., Gutierrez, C. R., Lidon, R. V., Allegretti, J., Török, H., Park, J., Leemreis, D., Fedorishina, O., Beaulieu, D., Glover, S., Randall, C., Rocca, R., Lördal, M., Holderman, W., Iskandar, H., Loy, L., Saibeni, S., Arranz, M. D. M., Tirado, M. R., Abraham, B., Hirten, R., Vanasek, T., Boughen, G., Desreumaux, P., Mohl, W., Kim, T., Meulen, A. V. D., Makarchuk, P., Farraye, F., & Kent, A. (2025). Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf163

Source records